Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 13  •  04:00PM ET
12.95
Dollar change
+0.14
Percentage change
1.09
%
Index- P/E- EPS (ttm)-4.43 Insider Own0.65% Shs Outstand199.50M Perf Week-5.89%
Market Cap2.58B Forward P/E8.76 EPS next Y1.48 Insider Trans-5.32% Shs Float198.26M Perf Month4.86%
Enterprise Value4.70B PEG- EPS next Q0.28 Inst Own99.50% Short Float7.32% Perf Quarter19.46%
Income-882.00M P/S0.71 EPS this Y-4.09% Inst Trans3.60% Short Ratio3.67 Perf Half Y-6.63%
Sales3.62B P/B1.75 EPS next Y-7.73% ROA-14.37% Short Interest14.51M Perf YTD13.30%
Book/sh7.41 P/C7.12 EPS next 5Y-0.38% ROE-44.44% 52W High19.27 -32.80% Perf Year-31.01%
Cash/sh1.82 P/FCF32.30 EPS past 3/5Y- - ROIC-24.64% 52W Low9.85 31.47% Perf 3Y-64.90%
Dividend Est.0.66 (5.06%) EV/EBITDA7.59 Sales past 3/5Y-3.58% -1.20% Gross Margin51.10% Volatility4.37% 4.11% Perf 5Y-76.60%
Dividend TTM0.64 (4.94%) EV/Sales1.30 EPS Y/Y TTM-113.81% Oper. Margin7.48% ATR (14)0.53 Perf 10Y-76.34%
Dividend Ex-DateDec 26, 2025 Quick Ratio0.99 Sales Y/Y TTM-7.08% Profit Margin-24.34% RSI (14)53.54 Recom2.89
Dividend Gr. 3/5Y14.17% 10.99% Current Ratio1.47 EPS Q/Q12.91% SMA201.41% Beta1.01 Target Price12.75
Payout- Debt/Eq1.68 Sales Q/Q-4.94% SMA507.10% Rel Volume1.68 Prev Close12.81
Employees14000 LT Debt/Eq1.42 EarningsFeb 26 AMC SMA200-4.70% Avg Volume3.96M Price12.95
IPOAug 12, 1987 Option/ShortYes / Yes EPS/Sales Surpr.-17.37% 0.82% Trades Volume6,654,255 Change1.09%
Date Action Analyst Rating Change Price Target Change
Dec-09-25Initiated Barclays Underweight $12
Nov-07-25Downgrade William Blair Outperform → Mkt Perform
Apr-15-25Downgrade Morgan Stanley Overweight → Equal-Weight $14
Mar-13-25Downgrade Needham Buy → Hold
Feb-14-25Initiated Wells Fargo Equal Weight $20
Jan-23-25Downgrade Jefferies Buy → Hold $30 → $20
Jan-07-25Downgrade Evercore ISI Outperform → In-line $20
Dec-04-24Initiated Mizuho Neutral $21
Nov-07-24Downgrade Leerink Partners Outperform → Market Perform
Oct-25-24Reiterated Needham Buy $34 → $29
Feb-09-26 07:40AM
Feb-06-26 07:52PM
Feb-05-26 04:15PM
Feb-04-26 05:30PM
Jan-28-26 11:03PM
08:15AM Loading…
Jan-26-26 08:15AM
Jan-21-26 12:21PM
Jan-15-26 11:43AM
Jan-14-26 08:00AM
Jan-13-26 04:30PM
08:00AM
Jan-12-26 09:00AM
Jan-08-26 07:44AM
Jan-06-26 04:15PM
03:06PM
10:34PM Loading…
Dec-24-25 10:34PM
Dec-15-25 08:00AM
Dec-11-25 06:39AM
Nov-12-25 08:27PM
Nov-11-25 06:40AM
Nov-10-25 09:15AM
Nov-07-25 10:15AM
Nov-06-25 04:01PM
03:12PM
11:36AM
10:39AM
10:00AM
09:15AM
08:14AM
08:00AM
10:21PM Loading…
Nov-04-25 10:21PM
08:39AM
Oct-30-25 10:00AM
Oct-24-25 10:40AM
Oct-15-25 02:01PM
Oct-13-25 08:01AM
Oct-10-25 03:50PM
Oct-08-25 04:15PM
Oct-02-25 08:30AM
Sep-23-25 11:31PM
Sep-21-25 09:26PM
Sep-16-25 09:29AM
Sep-10-25 09:02AM
Sep-08-25 08:30AM
12:03AM
Aug-26-25 04:30PM
08:22AM
Aug-21-25 09:45AM
Aug-19-25 01:41PM
05:59AM
Aug-18-25 04:06AM
Aug-14-25 10:35AM
Aug-11-25 09:15AM
Aug-08-25 09:45AM
07:25AM
Aug-07-25 02:15PM
01:49PM
11:06AM
09:40AM
09:30AM
07:15AM
06:49AM
06:00AM
Aug-06-25 12:50PM
Aug-05-25 11:10PM
Aug-04-25 11:40AM
09:40AM
08:35AM
Jul-31-25 10:00AM
Jul-30-25 05:30PM
Jul-28-25 09:50AM
12:01AM
Jul-22-25 11:16AM
09:40AM
06:00AM
Jul-21-25 04:07PM
03:04PM
12:21PM
08:30AM
Jul-18-25 11:40AM
09:40AM
09:28AM
Jul-16-25 12:26PM
Jul-14-25 09:26AM
08:33AM
Jul-10-25 08:30AM
Jul-09-25 09:50AM
Jul-03-25 09:40AM
Jul-02-25 11:40AM
09:40AM
Jun-27-25 05:38AM
Jun-25-25 11:31PM
Jun-17-25 09:40AM
Jun-16-25 11:40AM
09:40AM
Jun-12-25 08:34AM
Jun-11-25 10:28AM
Jun-05-25 05:35PM
07:47AM
Jun-04-25 09:50AM
Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment is engaged in designing, manufacturing, and selling dental technology and equipment products. The Essential Dental Solutions segment designs, manufactures, and sells value-added endodontic, restorative, and preventive consumable products. The Orthodontic and Implant Solutions segment designs, manufactures, and sells various digital implant systems and dental implant products. The Wellspect Healthcare segment designs, manufactures, and sells continence care solutions for management of both urinary and bowel dysfunction dental products. The company was founded in 1899 and is headquartered in Charlotte, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LUCIER GREGORY TDIRECTORDec 08 '25Proposed Sale11.1082,200912,420Dec 11 08:16 PM
LUCIER GREGORY TDirectorDec 08 '25Sale11.1482,200915,7080Dec 10 04:26 PM
VARON LESLIE FDirectorNov 24 '25Buy10.719,33799,99957,343Nov 25 05:26 PM
LUCIER GREGORY TDirectorMar 03 '25Buy16.5115,142249,99481,971Mar 03 06:33 PM
TEVA Teva- Pharmaceutical Industries Ltd. ADR daily Stock Chart
Index- P/E27.91 EPS (ttm)1.22 Insider Own0.16% Shs Outstand1.15B Perf Week-2.05%
Market Cap38.97B Forward P/E11.02 EPS next Y3.08 Insider Trans-28.78% Shs Float1.14B Perf Month4.11%
Enterprise Value52.61B PEG2.00 EPS next Q0.55 Inst Own63.25% Short Float3.31% Perf Quarter31.55%
Income1.42B P/S2.24 EPS this Y-7.72% Inst Trans-3.99% Short Ratio3.70 Perf Half Y93.73%
Sales17.39B P/B4.94 EPS next Y14.02% ROA3.54% Short Interest37.95M Perf YTD8.88%
Book/sh6.88 P/C10.96 EPS next 5Y5.52% ROE21.37% 52W High37.35 -9.01% Perf Year104.33%
Cash/sh3.10 P/FCF38.82 EPS past 3/5Y- - ROIC6.12% 52W Low12.47 172.60% Perf 3Y229.90%
Dividend Est.- EV/EBITDA10.51 Sales past 3/5Y5.53% 0.80% Gross Margin51.82% Volatility1.74% 3.04% Perf 5Y205.58%
Dividend TTM- EV/Sales3.03 EPS Y/Y TTM185.43% Oper. Margin22.96% ATR (14)0.93 Perf 10Y-39.05%
Dividend Ex-DateNov 27, 2017 Quick Ratio0.80 Sales Y/Y TTM4.72% Profit Margin8.16% RSI (14)57.82 Recom1.43
Dividend Gr. 3/5Y- - Current Ratio1.04 EPS Q/Q313.26% SMA201.39% Beta0.72 Target Price39.11
Payout0.00% Debt/Eq2.17 Sales Q/Q12.42% SMA506.56% Rel Volume0.49 Prev Close33.92
Employees33346 LT Debt/Eq1.93 EarningsJan 28 BMO SMA20054.12% Avg Volume10.27M Price33.98
IPOFeb 16, 1982 Option/ShortYes / Yes EPS/Sales Surpr.49.70% 9.13% Trades Volume5,001,533 Change0.18%
Date Action Analyst Rating Change Price Target Change
Dec-09-25Initiated Barclays Overweight $35
Dec-05-25Initiated Scotiabank Sector Outperform $35
Jun-06-25Initiated Goldman Buy $24
May-28-25Initiated Truist Buy $25
May-12-25Upgrade JP Morgan Neutral → Overweight $23
Jul-10-24Upgrade Argus Hold → Buy $20
Mar-08-24Upgrade JP Morgan Underweight → Neutral $14
Feb-12-24Upgrade Piper Sandler Neutral → Overweight $12 → $19
Jan-23-24Upgrade Jefferies Hold → Buy $10 → $14
Jan-03-24Upgrade Piper Sandler Underweight → Neutral $8 → $12
Feb-10-26 06:41AM
Feb-04-26 09:05AM
Feb-03-26 09:34PM
Feb-02-26 01:30AM
Jan-31-26 09:35AM
08:48AM Loading…
08:48AM
Jan-30-26 10:08AM
Jan-29-26 12:36PM
11:23AM
10:05AM
12:06AM
Jan-28-26 04:26PM
03:25PM
01:01PM
12:22PM
11:10AM Loading…
11:10AM
10:02AM
09:40AM
09:30AM
08:46AM
07:00AM
Jan-27-26 10:51AM
08:00AM
Jan-23-26 09:15AM
Jan-21-26 12:14PM
10:28AM
Jan-19-26 09:07AM
Jan-16-26 08:53AM
08:52AM
Jan-15-26 09:50AM
05:02PM Loading…
Jan-14-26 05:02PM
Jan-13-26 09:04PM
04:48PM
11:16AM
Jan-12-26 12:26PM
10:46AM
10:08AM
09:40AM
Jan-11-26 06:00PM
05:00PM
Jan-10-26 02:57PM
Jan-06-26 11:44AM
11:15AM
Jan-05-26 04:30PM
09:07AM
Dec-30-25 07:40AM
Dec-29-25 11:59PM
Dec-26-25 10:45AM
Dec-24-25 08:36AM
04:11AM
Dec-22-25 11:21AM
Dec-19-25 03:40AM
03:26AM
Dec-18-25 09:40AM
Dec-17-25 05:09PM
02:53PM
07:44AM
Dec-16-25 10:30AM
Dec-14-25 03:47PM
Dec-12-25 04:30PM
04:30PM
Dec-11-25 08:26PM
10:11AM
10:11AM
Dec-10-25 09:24PM
09:43AM
Dec-09-25 11:12AM
08:00AM
04:53AM
Dec-08-25 11:10AM
08:23AM
03:34AM
Dec-06-25 09:52AM
Dec-05-25 09:57AM
Dec-04-25 12:18PM
Dec-02-25 09:40AM
Nov-30-25 03:14AM
Nov-26-25 04:11PM
Nov-25-25 08:41AM
08:10AM
Nov-24-25 12:38PM
Nov-21-25 04:30PM
Nov-19-25 08:00AM
Nov-18-25 09:50AM
Nov-14-25 08:44AM
Nov-13-25 09:40AM
Nov-11-25 03:51AM
Nov-10-25 09:40AM
Nov-07-25 06:00PM
09:40AM
Nov-06-25 11:18AM
05:43AM
Nov-05-25 05:53PM
04:31PM
04:21PM
02:00PM
12:58PM
11:05AM
09:30AM
07:00AM
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Weiss AmirChief Accounting OfficerDec 16 '25Sale30.2012,300371,5045,650Dec 18 04:04 PM
MIGNONE ROBERTODirectorDec 16 '25Sale30.2477,4002,340,646367,600Dec 18 04:02 PM
Bridger Management, LLC (1)ShareholderDec 12 '25Proposed Sale30.18150,0004,527,000Dec 12 04:17 PM
Daniell RichardExec. VP, European CommercialDec 09 '25Option Exercise18.40115,4682,124,542163,852Dec 11 04:09 PM
Daniell RichardExec. VP, European CommercialDec 09 '25Sale28.68115,4683,311,12648,384Dec 11 04:09 PM
Sabag MarkSee "Remarks"Dec 09 '25Option Exercise18.61118,7242,209,454269,720Dec 11 04:06 PM
Sabag MarkSee "Remarks"Dec 09 '25Sale28.73216,8926,230,75452,828Dec 11 04:06 PM
Sabag MarkOfficerDec 09 '25Proposed Sale28.73216,8926,230,750Dec 09 04:03 PM
Daniell RichardOfficerDec 09 '25Proposed Sale28.68115,4683,311,131Dec 09 04:00 PM
MIGNONE ROBERTODirectorNov 26 '25Sale26.0350,0001,301,505445,000Dec 01 04:02 PM
Bridger Management, LLC (1)ShareholderNov 26 '25Proposed Sale24.9950,0001,249,500Nov 26 04:02 PM
Fox ChristineEVP, Head of U.S. CommercialNov 20 '25Sale24.7828,229699,52363,647Nov 24 04:03 PM
Fox ChristineOfficerNov 20 '25Proposed Sale24.7828,229699,523Nov 20 04:19 PM
Fox ChristineEVP, Head of U.S. CommercialNov 14 '25Sale25.1130,000753,32128,384Nov 18 04:01 PM
Fox ChristineOfficerNov 14 '25Proposed Sale25.1130,000753,321Nov 14 03:59 PM
MIGNONE ROBERTODirectorNov 06 '25Sale24.11200,0004,821,880495,000Nov 10 04:15 PM
Weiss AmirChief Accounting OfficerNov 06 '25Sale24.4412,300300,56417,950Nov 10 04:06 PM
Bridger Management, LLC (1)ShareholderSep 12 '25Proposed Sale19.8995,0001,889,550Sep 12 04:05 PM
McAvoy David R.EVP, Chief Legal OfficerSep 05 '25Buy18.861,11320,98813,027Sep 09 04:02 PM
Jover PlacidSee "Remarks"Aug 01 '25Sale15.166,05391,7486,774Aug 05 04:04 PM
Hughes Eric ASee "Remarks"Aug 01 '25Sale15.1652,742799,4370Aug 05 04:02 PM
Jover PlacidOfficerAug 01 '25Proposed Sale15.166,05391,748Aug 01 04:04 PM
Hughes Eric AOfficerAug 01 '25Proposed Sale15.1652,742799,437Aug 01 04:01 PM
Kalif Eliyahu SharonEVP, Chief Financial OfficerJun 12 '25Sale17.0855,775952,464403,288Jun 16 04:03 PM
Kalif Eliyahu SharonOfficerJun 12 '25Proposed Sale17.0855,775952,466Jun 12 04:18 PM
Shields MatthewEVP, Global OperationsJun 03 '25Sale17.026,206105,6289,989Jun 05 05:08 PM
Shields MatthewOfficerJun 03 '25Proposed Sale17.026,206105,628Jun 03 03:59 PM
Sabag MarkSee "Remarks"May 08 '25Sale18.04337,9156,097,304150,996May 12 04:00 PM
Sabag MarkOfficerMay 08 '25Proposed Sale18.04337,9156,097,324May 08 02:34 PM
Daniell RichardExec. VP, European CommercialMar 05 '25Sale15.9170,9611,128,64248,384Mar 07 04:05 PM
Hughes Eric ASee "Remarks"Mar 04 '25Sale15.7315,174238,7578,077Mar 06 04:11 PM
Hughes Eric ASee "Remarks"Mar 05 '25Sale15.918,077128,5310Mar 06 04:11 PM
Daniell RichardExec. VP, European CommercialMar 04 '25Sale15.7391,6081,441,4157,108Mar 06 04:06 PM
Daniell RichardExec. VP, European CommercialMar 05 '25Sale15.9148,764775,9910Mar 06 04:06 PM
Francis Richard DPresident and CEOMar 04 '25Sale15.7315,514244,107280,042Mar 06 04:03 PM
Francis Richard DPresident and CEOMar 05 '25Sale15.918,259131,427271,783Mar 06 04:03 PM
Daniell RichardOfficerMar 05 '25Proposed Sale15.8370,9611,123,585Mar 05 04:29 PM
Daniell RichardExec. VP, European CommercialMar 03 '25Sale16.1949,314798,17212,936Mar 05 04:12 PM
Daniell RichardExec. VP, European CommercialMar 04 '25Sale15.5612,936201,2530Mar 05 04:12 PM
Hughes Eric ASee "Remarks"Mar 03 '25Sale16.1919,726319,2755,174Mar 05 04:08 PM
Hughes Eric ASee "Remarks"Mar 04 '25Sale15.565,17480,4950Mar 05 04:08 PM
Francis Richard DPresident and CEOMar 03 '25Sale16.1924,892402,889251,783Mar 05 04:04 PM
Francis Richard DPresident and CEOMar 04 '25Sale15.566,450100,347245,333Mar 05 04:04 PM
Fox ChristineOfficerMar 04 '25Proposed Sale16.006,18198,896Mar 04 07:02 PM
McAvoy David R.OfficerMar 04 '25Proposed Sale16.004,82777,232Mar 04 06:57 PM
Hughes Eric AOfficerMar 04 '25Proposed Sale16.0023,251372,016Mar 04 06:44 PM
Daniell RichardOfficerMar 04 '25Proposed Sale16.0086,4001,382,400Mar 04 06:37 PM
Francis Richard DOfficerMar 04 '25Proposed Sale16.0023,773380,368Mar 04 06:30 PM
Kalif Eliyahu SharonEVP, Chief Financial OfficerFeb 28 '25Sale16.2155,750903,462147,941Mar 04 04:02 PM
Francis Richard DOfficerMar 03 '25Proposed Sale16.4631,342515,889Mar 03 01:14 PM
Hughes Eric AOfficerMar 03 '25Proposed Sale16.4624,900409,854Mar 03 01:07 PM
Daniell RichardOfficerMar 03 '25Proposed Sale16.4662,2501,024,635Mar 03 12:59 PM
Kalif Eliyahu SharonOfficerFeb 28 '25Proposed Sale16.2155,750903,463Feb 28 11:52 AM
Francis Richard DPresident and CEOFeb 18 '25Sale16.9575,5061,279,661209,444Feb 19 04:03 PM
Francis Richard DOfficerFeb 18 '25Proposed Sale16.9575,5061,279,661Feb 18 12:38 PM
Last Close
Feb 13  •  04:00PM ET
101.45
Dollar change
+1.45
Percentage change
1.45
%
CHD Church & Dwight Co., Inc daily Stock Chart
IndexS&P 500 P/E33.70 EPS (ttm)3.01 Insider Own0.22% Shs Outstand240.13M Perf Week0.92%
Market Cap24.01B Forward P/E25.17 EPS next Y4.03 Insider Trans-2.39% Shs Float239.60M Perf Month12.52%
Enterprise Value25.99B PEG3.60 EPS next Q0.93 Inst Own90.67% Short Float4.16% Perf Quarter18.82%
Income736.80M P/S3.87 EPS this Y6.74% Inst Trans-1.36% Short Ratio3.93 Perf Half Y9.56%
Sales6.20B P/B6.00 EPS next Y6.96% ROA8.28% Short Interest9.97M Perf YTD20.99%
Book/sh16.92 P/C58.71 EPS next 5Y7.00% ROE17.62% 52W High116.46 -12.89% Perf Year-5.65%
Cash/sh1.73 P/FCF21.97 EPS past 3/5Y21.52% -0.65% ROIC11.58% 52W Low81.33 24.74% Perf 3Y21.66%
Dividend Est.1.23 (1.21%) EV/EBITDA20.17 Sales past 3/5Y4.89% 4.85% Gross Margin42.78% Volatility2.44% 2.31% Perf 5Y22.32%
Dividend TTM1.19 (1.18%) EV/Sales4.19 EPS Y/Y TTM26.45% Oper. Margin17.37% ATR (14)2.24 Perf 10Y129.06%
Dividend Ex-DateFeb 13, 2026 Quick Ratio0.71 Sales Y/Y TTM1.57% Profit Margin11.88% RSI (14)74.05 Recom2.30
Dividend Gr. 3/5Y3.97% 4.21% Current Ratio1.07 EPS Q/Q-21.65% SMA205.62% Beta0.46 Target Price103.65
Payout39.12% Debt/Eq0.60 Sales Q/Q3.93% SMA5013.42% Rel Volume1.09 Prev Close100.00
Employees5550 LT Debt/Eq0.59 EarningsJan 30 BMO SMA20010.93% Avg Volume2.54M Price101.45
IPOMar 17, 1980 Option/ShortYes / Yes EPS/Sales Surpr.2.87% 0.33% Trades Volume2,774,157 Change1.45%
Date Action Analyst Rating Change Price Target Change
Feb-13-26Upgrade Rothschild & Co Redburn Sell → Neutral $91
Feb-02-26Upgrade JP Morgan Underweight → Neutral $100
Jan-05-26Upgrade Raymond James Mkt Perform → Outperform $100
Dec-17-25Upgrade Jefferies Hold → Buy $102
Dec-17-25Upgrade Citigroup Sell → Neutral $87
Jul-14-25Downgrade Rothschild & Co Redburn Neutral → Sell $83
Jun-02-25Upgrade RBC Capital Mkts Sector Perform → Outperform $114
May-06-25Downgrade TD Cowen Buy → Hold $100
Apr-15-25Upgrade BofA Securities Neutral → Buy $125
Sep-24-24Initiated Piper Sandler Overweight $120
Feb-13-26 09:12AM
Feb-12-26 10:42AM
08:45AM
Feb-09-26 10:31PM
Feb-03-26 10:17PM
09:47AM Loading…
Feb-02-26 09:47AM
Jan-30-26 10:48PM
06:01PM
05:10PM
04:43PM
10:47AM
09:30AM
09:26AM
08:05AM
07:40AM
07:21AM Loading…
07:21AM
07:11AM
06:55AM
Jan-29-26 12:27PM
Jan-28-26 10:02PM
Jan-23-26 10:00AM
Jan-22-26 07:53AM
Jan-20-26 12:36PM
Jan-19-26 12:40PM
Jan-13-26 11:14AM
07:35AM
Jan-11-26 04:45PM
Jan-08-26 11:46AM
09:38AM
Jan-07-26 11:40AM
12:58PM Loading…
Jan-05-26 12:58PM
09:25AM
Jan-02-26 06:57AM
Dec-30-25 03:30PM
12:01AM
Dec-28-25 10:36PM
Dec-23-25 11:35PM
12:37PM
Dec-15-25 11:38PM
Dec-11-25 02:16AM
Dec-10-25 11:36PM
01:51PM
Dec-09-25 04:30PM
02:58AM
Dec-05-25 09:53AM
06:08AM
Dec-04-25 08:19AM
Dec-03-25 11:33PM
Dec-02-25 11:39AM
Nov-26-25 11:09AM
09:58AM
Nov-25-25 11:02PM
Nov-24-25 12:39AM
Nov-23-25 05:58PM
Nov-13-25 11:42PM
Nov-12-25 02:54PM
12:32PM
07:00AM
Nov-11-25 08:26AM
Nov-10-25 01:05PM
Nov-07-25 09:12AM
12:33AM
Nov-03-25 10:01AM
Oct-31-25 05:01PM
03:41PM
10:00AM
09:30AM
08:05AM
07:13AM
07:04AM
06:55AM
Oct-29-25 11:02PM
10:26PM
Oct-27-25 04:13PM
Oct-24-25 09:36PM
10:00AM
08:11AM
08:10AM
Oct-17-25 12:45PM
12:44AM
Sep-30-25 10:53AM
12:36AM
Sep-22-25 05:06PM
Sep-16-25 08:28AM
Sep-15-25 11:39AM
Sep-12-25 11:40AM
02:51AM
Sep-11-25 11:43AM
Sep-09-25 11:00AM
Sep-04-25 03:45AM
Sep-03-25 11:30AM
12:00AM
Aug-27-25 11:33PM
12:08PM
11:40AM
Aug-26-25 12:42AM
Aug-20-25 08:40PM
03:28PM
12:05PM
03:48AM
Church & Dwight Co., Inc. engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements. The Consumer International segment is involved in the personal care, household and over-the-counter products in international subsidiary markets, including Australia, Canada, France, Germany, Japan, Mexico, China, and the United Kingdom. The SPD segment consists of sales to businesses and participates in three product areas namely, animal nutrition, specialty chemicals, and commercial and professional. The Corporate segment includes equity in earnings of affiliates. The company was founded by Dwight John and Austin Church in 1846 and is headquartered in Ewing, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vergis Janet S.DirectorFeb 04 '26Option Exercise49.6212,960643,07530,062Feb 05 12:24 PM
Vergis Janet S.DirectorFeb 04 '26Sale101.0012,9601,308,96017,102Feb 05 12:24 PM
Janet VergisOfficerFeb 04 '26Proposed Sale100.1412,9601,297,814Feb 04 02:00 PM
Dierker Richard APresident and CEOAug 12 '25Buy91.575,470500,88827,212Aug 12 12:17 PM
McChesney Lee BEVP, Chief Financial OfficerAug 08 '25Buy91.385,409494,2475,409Aug 11 01:29 PM
Read MichaelEVP, InternationalAug 05 '25Buy91.272,000182,5407,505Aug 06 12:36 PM
Hooker CarlenEVP, Chief Commercial OfficerJun 16 '25Option Exercise84.856,380541,3436,642Jun 17 09:29 AM
Hooker CarlenEVP, Chief Commercial OfficerJun 16 '25Sale98.306,380627,161262Jun 17 09:29 AM
Carlen G HookerOfficerJun 13 '25Proposed Sale99.006,380631,620Jun 13 11:42 AM
Hooker CarlenEVP, Chief Commercial OfficerMay 30 '25Option Exercise79.0511,875938,7125,742Jun 02 12:03 PM
Hooker CarlenEVP, Chief Commercial OfficerMay 30 '25Sale98.7511,8751,172,656262Jun 02 12:03 PM
Saligram Ravichandra KrishnamuDirectorMay 30 '25Option Exercise41.9114,660614,47428,407Jun 02 11:45 AM
Saligram Ravichandra KrishnamuDirectorMay 30 '25Sale99.0014,6601,451,34013,747Jun 02 11:45 AM
RAVICHANDRA K SALIGRAMDirectorMay 30 '25Proposed Sale97.8914,6601,435,067May 30 01:08 PM
Hooker CarlenEVP, Chief Commercial OfficerMay 29 '25Option Exercise73.873,000221,6103,262May 30 09:43 AM
Hooker CarlenEVP, Chief Commercial OfficerMay 29 '25Sale98.053,000294,158262May 30 09:43 AM
Carlen G HookerOfficerMay 29 '25Proposed Sale98.1814,8751,460,428May 29 10:19 AM
Dierker Richard APresident and CEOMay 13 '25Buy94.667,950752,57916,358May 14 10:43 AM
Dierker Richard APresident and CEOMay 14 '25Buy92.805,384499,63519,092May 14 10:43 AM
Read MichaelEVP, InternationalMay 09 '25Buy92.073,000276,2215,505May 09 11:01 AM
Price Penry WDirectorMay 08 '25Option Exercise41.9114,660614,47441,703May 09 09:14 AM
Price Penry WDirectorMay 08 '25Sale93.1314,6601,365,28627,043May 09 09:14 AM
Penry PriceDirectorMay 08 '25Proposed Sale92.4514,6601,355,317May 08 11:56 AM
Hooker CarlenEVP, Chief Commercial OfficerApr 03 '25Option Exercise0.003670367Apr 04 02:50 PM
Hemsey ReneEVP, Chief HR OfficerMar 12 '25Option Exercise45.5111,060503,33812,337Mar 13 09:55 AM
Hemsey ReneEVP, Chief HR OfficerMar 12 '25Sale109.9811,0601,216,3926,437Mar 13 09:55 AM
Rene HemseyOfficerMar 11 '25Proposed Sale112.0011,0601,238,720Mar 11 01:46 PM
DE MAYNADIER PATRICK DEVP, Gen. Counsel & SecretaryMar 10 '25Option Exercise73.8754,5104,026,65465,007Mar 11 11:37 AM
DE MAYNADIER PATRICK DEVP, Gen. Counsel & SecretaryMar 10 '25Sale115.9854,5106,321,86310,497Mar 11 11:37 AM
FARRELL MATTHEWPresident and CEOMar 03 '25Sale111.2104114,611Mar 05 11:13 AM
PATRICK DE MAYNADIEROfficerMar 05 '25Proposed Sale114.0095,85010,926,900Mar 05 10:51 AM